Inogen to Provide Strategy Update on February 27, 2023
February 23 2023 - 4:10PM
Business Wire
Inogen, Inc. (Nasdaq: INGN), a medical technology company
offering innovative respiratory products for use in the homecare
setting, today announced that it will host a conference call on
Monday, February 27, 2023, at 10:00 a.m. Eastern Time. At the
event, Nabil Shabshab, President and Chief Executive Officer, and
Kristin Caltrider, Chief Financial Officer, will provide an update
on the Company’s commercial and innovation strategies.
A live audio webcast and archived recording of the presentation
will be available to all interested parties through the News /
Events page on the Inogen Investor Relations website.
Inogen has used, and intends to continue to use, its Investor
Relations website, http://investor.inogen.com/, as a means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD. For more
information, visit http://investor.inogen.com/.
About Inogen
Inogen, Inc. (Nasdaq: INGN) is a leading global medical
technology company offering innovative respiratory products for use
in the homecare setting. Inogen supports patient respiratory care
by developing, manufacturing, and marketing innovative
best-in-class portable oxygen concentrators used to deliver
supplemental long-term oxygen therapy to patients suffering from
chronic respiratory conditions. Inogen partners with patients,
prescribers, home medical equipment providers, and distributors to
make its oxygen therapy products widely available allowing patients
the chance to remain ambulatory while managing the impact of their
disease.
For more information, please visit www.inogen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230223005533/en/
Agnes Lee ir@inogen.net
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Apr 2023 to Apr 2024